These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 18047610)
1. Submental fat reduction by mesotherapy using phosphatidylcholine alone vs. phosphatidylcholine and organic silicium: a pilot study. Co AC; Abad-Casintahan MF; Espinoza-Thaebtharm A J Cosmet Dermatol; 2007 Dec; 6(4):250-7. PubMed ID: 18047610 [TBL] [Abstract][Full Text] [Related]
2. Randomized double-blind clinical trial of subcutaneously injected deoxycholate versus a phosphatidylcholine-deoxycholate combination for the reduction of submental fat. Rotunda AM; Weiss SR; Rivkin LS Dermatol Surg; 2009 May; 35(5):792-803. PubMed ID: 19397673 [TBL] [Abstract][Full Text] [Related]
3. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Rotunda AM; Kolodney MS Dermatol Surg; 2006 Apr; 32(4):465-80. PubMed ID: 16681654 [TBL] [Abstract][Full Text] [Related]
4. The effectiveness and safety of topical PhotoActif phosphatidylcholine-based anti-cellulite gel and LED (red and near-infrared) light on Grade II-III thigh cellulite: a randomized, double-blinded study. Sasaki GH; Oberg K; Tucker B; Gaston M J Cosmet Laser Ther; 2007 Jun; 9(2):87-96. PubMed ID: 17558758 [TBL] [Abstract][Full Text] [Related]
5. Phosphatidylcholine in the treatment of localized fat. Hexsel D; Serra M; Mazzuco R; Dal'Forno T; Zechmeister D J Drugs Dermatol; 2003 Oct; 2(5):511-8. PubMed ID: 14558399 [TBL] [Abstract][Full Text] [Related]
6. Use of phosphatidylcholine for the correction of lower lid bulging due to prominent fat pads. Treacy PJ; Goldberg DJ J Cosmet Laser Ther; 2006 Sep; 8(3):129-32. PubMed ID: 16971361 [TBL] [Abstract][Full Text] [Related]
7. Injection lipolysis for reduction of saddlebag trochanteric bulges--half-side controlled pilot study. Kopera D; Horejsi R; Werner S; Moeller R J Dtsch Dermatol Ges; 2008 Apr; 6(4):287-90. PubMed ID: 18081857 [TBL] [Abstract][Full Text] [Related]
8. The use of phosphatidylcholine for correction of localized fat deposits. Rittes PG Aesthetic Plast Surg; 2003; 27(4):315-8. PubMed ID: 15058557 [TBL] [Abstract][Full Text] [Related]
9. Histological changes associated with mesotherapy for fat dissolution. Rose PT; Morgan M J Cosmet Laser Ther; 2005 Mar; 7(1):17-9. PubMed ID: 16020211 [TBL] [Abstract][Full Text] [Related]
10. Treatment of aging neck with Lipostabil Endovena. Rittes PG; Rites C J Drugs Dermatol; 2009 Oct; 8(10):937-9. PubMed ID: 19852123 [TBL] [Abstract][Full Text] [Related]
11. Injection of phosphatidylcholine in fat tissue: experimental study of local action in rabbits. Rittes PG; Rittes JC; Carriel Amary MF Aesthetic Plast Surg; 2006; 30(4):474-8. PubMed ID: 16858660 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of mesotherapeutic injections of three different combinations of lipolytic agents for body contouring. Kutlubay Z J Cosmet Laser Ther; 2011 Aug; 13(4):142-53. PubMed ID: 21718184 [TBL] [Abstract][Full Text] [Related]
13. Perceptions and practices in submental fat treatment: a survey of physicians and patients. Schlessinger J; Weiss SR; Jewell M; Narurkar V; Weinkle S; Gold MH; Bazerkanian E Skinmed; 2013; 11(1):27-31. PubMed ID: 23540074 [TBL] [Abstract][Full Text] [Related]
14. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Rotunda AM; Suzuki H; Moy RL; Kolodney MS Dermatol Surg; 2004 Jul; 30(7):1001-8. PubMed ID: 15209790 [TBL] [Abstract][Full Text] [Related]
15. Tissue-toxic effects of phosphatidylcholine/deoxycholate after subcutaneous injection for fat dissolution in rats and a human volunteer. Schuller-Petrovic S; Wölkart G; Höfler G; Neuhold N; Freisinger F; Brunner F Dermatol Surg; 2008 Apr; 34(4):529-42; discussion 542-3. PubMed ID: 18370980 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. Elwatidy S; Jamjoom Z; Elgamal E; Zakaria A; Turkistani A; El-Dawlatly A Spine (Phila Pa 1976); 2008 Nov; 33(24):2577-80. PubMed ID: 19011538 [TBL] [Abstract][Full Text] [Related]
17. Histological changes after treatment for localized fat deposits with phosphatidylcholine and sodium deoxycholate. Park EJ; Kim HS; Kim M; Oh HJ J Cosmet Dermatol; 2013 Sep; 12(3):240-3. PubMed ID: 23992167 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD). Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776 [TBL] [Abstract][Full Text] [Related]
19. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study. Hurwitz BJ; Jeffery D; Arnason B; Bigley K; Coyle P; Goodin D; Kaba S; Kirzinger S; Lynch S; Mandler R; Mikol D; Rammohan K; Sater R; Sriram S; Thrower B; Boateng F; Jakobs P; Wash MB; Bogumil T Clin Ther; 2008 Jun; 30(6):1102-12. PubMed ID: 18640466 [TBL] [Abstract][Full Text] [Related]
20. Effects of intravenous patient-controlled analgesia with buprenorphine and morphine alone and in combination during the first 12 postoperative hours: a randomized, double-blind, four-arm trial in adults undergoing abdominal surgery. Oifa S; Sydoruk T; White I; Ekstein MP; Marouani N; Chazan S; Skornick Y; Weinbroum AA Clin Ther; 2009 Mar; 31(3):527-41. PubMed ID: 19393843 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]